Acalabrutinib-Related Cardiac Toxicities in Patients with Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials

Acalabrutinib-Related Cardiac Toxicities in Patients with Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials

Acalabrutinib, a second-generation and more selective Bruton's tyrosine kinase inhibitor, was developed to potentiate efficacy while minimizing ibrutinib-associated side effects. We undertook a systematic review and meta-analysis of randomized clinical trials to determine the risks of acalabrut...

Full description

Bibliographic Details
Main Authors:	Thura Win Htut, Myat Min Han, Kyaw Zin Thein
Format:	Article
Language:	English
Published:	Innovative Healthcare Institute 2022-05-01
Series:	Journal of Immunotherapy and Precision Oncology
Subjects:	acalabrutinib cardiac toxicities atrial fibrillation hypertension chronic lymphocytic leukemia
Online Access:	https://theijpt.org/doi/pdf/10.36401/JIPO-21-12

Similar Items

Distinct Effects of Ibrutinib and Acalabrutinib on Mouse Atrial and Sinoatrial Node Electrophysiology and Arrhythmogenesis
by: Jari M. Tuomi, et al.
Published: (2021-11-01)

Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysis
by: Joachim Alexandre, et al.
Published: (2025-03-01)

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia
by: Samir Mouhssine, et al.
Published: (2024-04-01)

The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View
by: Tambaro FP, et al.
Published: (2021-10-01)

Data Mining for Adverse Events Signals of Acalabrutinib Based on FAERS Database
by: LIANG Cuilyu, et al.
Published: (2022-11-01)

Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
by: Peihao Zheng, et al.
Published: (2025-02-01)

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia
by: Keisuke Kidoguchi, et al.
Published: (2021-02-01)

BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: Lorenzo Falchi, et al.
Published: (2016-02-01)

Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib
by: Diamond R. Guy, BS, et al.
Published: (2024-05-01)

Value of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Predicting Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection
by: Fatih Sivri, et al.
Published: (2022-10-01)

Bowel, lung, and retinal ischemia: Rare manifestations of leukostasis syndrome in a man with chronic lymphocytic leukemia—A case report and review of the literature
by: Bowen He, et al.
Published: (2023-09-01)

Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib – Case report
by: Aisling Barrett, et al.
Published: (2024-02-01)

Subacute postoperative atrial fibrillation after heart surgery: Incidence and predictive factors in cardiac rehabilitation
by: Vincenzo Rizza, et al.
Published: (2024-02-01)

In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
by: Deanna M. Mudie, et al.
Published: (2021-08-01)

Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs
by: Deanna M. Mudie, et al.
Published: (2021-04-01)

Detection of Perforin in suspension of leukemia lymphocyte culture
by: Najwa Sh. Ahmed, et al.
Published: (2014-01-01)

Increased Cardiac Arrhythmia After Pregnancy‐Induced Hypertension: A South Korean Nationwide Database Study
by: Yoonjee Park, et al.
Published: (2022-01-01)

An Ultrafast UPLC–MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib
by: Mohamed W. Attwa, et al.
Published: (2023-10-01)

Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
by: Ivana Milosevic
Published: (2016-11-01)

Gingival Leukemic Infiltration in Chronic Lymphocytic Leukemia
by: Karima Kacem, et al.
Published: (2019-11-01)

Meningeal involvement in chronic lymphocytic leukemia
by: S. N. Menshakova, et al.
Published: (2022-11-01)

Infections in patients with chronic lymphocytic leukemia
by: Mariana Guarana, et al.
Published: (2023-07-01)

Predictive value of neutrophil‐to‐lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study
by: Carlin Chang, et al.
Published: (2023-01-01)

Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma – A case report
by: Anna Nikkarinen, et al.
Published: (2024-08-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
by: Nuri Köse, et al.
Published: (2022-01-01)

THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti
Published: (2013-04-01)

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review)
by: T. E. Byalik
Published: (2018-07-01)

Simultaneous Occurrence of Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia: A Case Report
by: Stjepan Galić, et al.
Published: (2023-01-01)

Simultaneous Chronic Lymphocytic Leukemia and Hairy Cell Leukemia: a Sporadic Event? A Semantic Point of View.
by: luiza akria, et al.
Published: (2014-08-01)

Evaluation of Micronucleus and Nuclear Division Index in the Lymphocytes of some Iraqi Patients with Acute Lymphocyte Leukemia
by: Wiaam A. Al Amili, et al.
Published: (2013-12-01)

Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors
by: Mesut Ayer, et al.
Published: (2018-09-01)

Diagnosis of large granular lymphocytic leukemia in a patient previously treated for acute myeloblastic leukemia
by: Sinem Civriz Bozdag, et al.
Published: (2013-12-01)

A case of Norwegian scabies in a patient with leukemia cutis secondary to chronic lymphocytic leukemia
by: Minu Mathew, et al.
Published: (2020-11-01)

Probable ponatinib-induced papilledema in a patient with acute lymphocytic leukemia
by: Jared A. Moon, et al.
Published: (2023-12-01)

Preoperative serum potassium levels as a risk factor in postoperative atrial fibrillation in open cardiac surgery patient: A retrospective, observational study
by: Anak Agung Ayu Ngurah Desy Widya Putri, et al.
Published: (2023-01-01)

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)
by: Mehrdad Payandeh, et al.
Published: (2014-12-01)

Role of Autophagy in Proteostasis: Friend and Foe in Cardiac Diseases
by: Jin Li, et al.
Published: (2018-12-01)

The association between platelet to lymphocyte ratio and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation
by: Mujgan Tek, et al.
Published: (2022-06-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01)

ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Patrizia Chiusolo, et al.
Published: (2010-05-01)